Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
New Kaiser Permanente study aims to help providers improve the health of patients most likely to sustain high medical costs, frequently use the emergency department, or need to be hospitalized.
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
Kaiser Permanente Division of Research staff scientist Paola Gilsanz, ScD, is exploring the reasons for the unequal distribution of dementia risk among genders and ethnic groups.
Kaiser Permanente investigator Andrew Karter and colleagues will receive $3.2 million over 5 years from the National Institute on Aging to study what older patients with diabetes want from their treatment.
Genetics research suggests that longer telomeres — the “end caps” of DNA that keep strands of chromosomes from unraveling — mean more years of healthy life ahead.
Kaiser Permanente Division of Research scientists recently presented new research on associations between hazardous drinking, heart failure and HIV at the International AIDS Conference in Amsterdam.
Analysis of DNA from nearly 70,000 Kaiser Permanente Northern California patients uncovered 47 specific positions, or loci, in the genome that are associated with variations in pressure inside the eye. The findings could help clarify how elevated eye pressure leads to glaucoma.